Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K
5.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.8K
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibition.

Molecular cancer therapeutics·2026
Same author

Involvement of the FGF8/FGF Receptor Signaling Pathway in the Maintenance and Progression of Fusion-Positive Rhabdomyosarcoma.

Molecular cancer therapeutics·2025
Same author

Involvement of the FGF8/FGF Receptor Signaling Pathway in the Maintenance and Progression of Fusion-Positive Rhabdomyosarcoma.

Molecular cancer therapeutics·2025
Same author

DNA methylation patterns are influenced by Pax3::Foxo1 expression and developmental lineage in rhabdomyosarcoma tumours forming in genetically engineered mouse models.

The Journal of pathology·2025
Same author

Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity.

Cancer research communications·2023
Same author

Rhabdomyosarcomas are oncogene addicted to the activation of AVIL.

Proceedings of the National Academy of Sciences of the United States of America·2023

Related Experiment Video

Updated: Mar 15, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.7K

Gene Amplification in Rhabdomyosarcoma: Lessons from a Rare Cancer.

Frederic G Barr1

  • 1Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

International Journal of Molecular Sciences
|March 14, 2026
PubMed
Summary

Gene amplification in alveolar rhabdomyosarcoma involves diverse chromosomal regions and targets, including protein-coding and non-coding genes. Understanding these complex amplifications is crucial for developing effective cancer treatments and prognostic markers.

Keywords:
CDK4MIR17HGMYCNPAX3::FOXO1PAX7::FOXO1SHMT2alveolar rhabdomyosarcomagene amplification

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.0K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.9K

Related Experiment Videos

Last Updated: Mar 15, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.7K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.0K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.9K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Alveolar rhabdomyosarcoma is a pediatric soft tissue cancer.
  • Gene amplification is a key process in cancer development.
  • Previous studies have identified various molecular changes in this cancer.

Purpose of the Study:

  • To investigate the diverse molecular changes associated with gene amplification in alveolar rhabdomyosarcoma.
  • To analyze specific chromosomal regions and their amplified targets.
  • To explore the prognostic significance and therapeutic implications of these amplifications.

Main Methods:

  • Analysis of amplicons from chromosomal regions 2p24, 12q13-q14, 1p36, 13q14, and 13q31.
  • Identification of protein-coding (MYCN, CDK4, SHMT2) and non-coding RNA (MIR17HG) targets.
  • Examination of gene fusions (PAX7::FOXO1) in conjunction with amplification.
  • Translational studies for prognostic significance.
  • Preclinical investigations of drug susceptibility.

Main Results:

  • Amplification at 2p24 involves MYCN.
  • 12q13-q14 amplification targets oncogenes CDK4 and SHMT2.
  • 1p36 and 13q14 amplifications co-occur with PAX7::FOXO1 fusion.
  • 13q31 amplification targets the non-coding RNA gene MIR17HG.
  • Amplifications impact drug susceptibility, affecting targeted therapies and downstream signaling pathways.

Conclusions:

  • Gene amplification in alveolar rhabdomyosarcoma is complex, involving diverse chromosomal regions and targets.
  • Amplified genes can influence cancer prognosis and therapeutic response.
  • Understanding these amplifications is vital for advancing treatment strategies and identifying reliable prognostic markers.